Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07569289
PHASE2

Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

Sponsor: Bedaya Hospital

View on ClinicalTrials.gov

Summary

The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation

Official title: Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger . A Randomized Controlled Study

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

164

Start Date

2026-06-01

Completion Date

2028-04-01

Last Updated

2026-05-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

Double trigger

Triptorelin (0.2 mg/S.C ) and HCG (10000 IU/I.M) are administered 38 to 39 h and 35 to 36 h prior to ovum pick-up., respectively.

DRUG

HCG trigger

HCG (10000 IU/I.M) is administered 35 to 36 h prior to ovum pick-up.

Locations (1)

Bedaya Hospital

Giza, Giza Governorate, Egypt